Skip to main content
Fig. 5 | Cancer Nanotechnology

Fig. 5

From: Emodin-loaded polymer-lipid hybrid nanoparticles enhance the sensitivity of breast cancer to doxorubicin by inhibiting epithelial–mesenchymal transition

Fig. 5

Cellular uptake and cytotoxicity study of E-PLNs. A confocal imaging of C-6 PLNs in MCF-7/ADR cells was observed. B, C Flow cytometry and fluorescence intensity of nanoparticles uptake by MCF-7/ADR cells, N = 3, **p < 0.01, ***p < 0.001 compared with Control group. D, E Cell viability in vitro on MCF-7/ADR cells after treatment with free EMO and E-PLNs. F The cell viability of MCF-7/ADR cells treated with 30 μM EMO or E-PLNs combined with different concentrations of DOX (1.56–200 μM)

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us